Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey

Table 2 Antimicrobial resistance per selected microorganism-antimicrobial combinations

Microorganism	N tested with results*	N non-susceptible	Non-susceptible, %
Staphylococcus aureus / MRSA	39	21	53.8
Enterococci, GLY-R	68	35	51.5
Enterococcus faecalis	21	5	23.8
Enterococcus faecium	41	27	65.9
Enterobacteriaceae, 3GC-NS	205	125	61.0
Escherichia coli / 3GC-NS	30	6	20.0
Klebsiella spp. / 3GC-NS	134	105	78.4
Enterobacter spp. / 3GC-NS	12	3	25.0
Enterobacteriaceae, CAR-NS	171	80	46.8
Escherichia coli / CAR-NS	24	2	8.3
Klebsiella spp. / CAR-NS	114	73	64.0
Enterobacter spp. / CAR-NS	11	1	9.1
*Pseudomonas aeruginosa, CAR-NS*	121	79	65.3
*Acinetobacter baumannii, CAR-NS*	150	143	95.3

*Isolates are shown only if more than 10 microorganisms in each group were reported
MRSA, methicillin-resistant Staphylococcus aureus; GLY, glycopeptides; VRE, vancomycin-resistant Enterococci; 3GC, third-generation cephalosporins; CAR, carbapenems; NS, non-susceptible to standard dosing

ISSN: 2047-2994